BlackRock Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $90.4M | Buy |
1,091,545
+51,530
| +5% | +$4.27M | 0.04% | 454 |
|
|
2016
Q3 | $96.2M | Buy |
1,040,015
+16,645
| +2% | +$1.54M | 0.05% | 422 |
|
|
2016
Q2 | $79.6M | Sell |
1,023,370
-77,394
| -7% | -$6.02M | 0.04% | 457 |
|
|
2016
Q1 | $90.8M | Sell |
1,100,764
-385
| -0% | -$31.8K | 0.05% | 409 |
|
|
2015
Q4 | $115M | Buy |
1,101,149
+34,211
| +3% | +$3.58M | 0.06% | 346 |
|
|
2015
Q3 | $112M | Sell |
1,066,938
-8,498
| -0.8% | -$895K | 0.07% | 331 |
|
|
2015
Q2 | $147M | Sell |
1,075,436
-92,586
| -8% | -$12.7M | 0.08% | 280 |
|
|
2015
Q1 | $146M | Sell |
1,168,022
-54,128
| -4% | -$6.75M | 0.08% | 294 |
|
|
2014
Q4 | $110M | Sell |
1,222,150
-43,489
| -3% | -$3.93M | 0.06% | 364 |
|
|
2014
Q3 | $91.3M | Buy |
1,265,639
+105,888
| +9% | +$7.64M | 0.05% | 404 |
|
|
2014
Q2 | $72.1M | Sell |
1,159,751
-119,889
| -9% | -$7.46M | 0.04% | 463 |
|
|
2014
Q1 | $87.3M | Buy |
1,279,640
+544,559
| +74% | +$37.1M | 0.05% | 390 |
|
|
2013
Q4 | $51.7M | Buy |
735,081
+21,923
| +3% | +$1.54M | 0.03% | 531 |
|
|
2013
Q3 | $51.5M | Buy |
713,158
+228,100
| +47% | +$16.5M | 0.03% | 525 |
|
|
2013
Q2 | $27M | Buy |
+485,058
| New | +$27M | 0.02% | 641 |
|